Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.

MLA

Bolcaen, Julie, et al. “Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.” Pharmaceuticals (Basel, Switzerland), vol. 14, no. 7, June 2021. EBSCOhost, https://doi.org/10.3390/ph14070626.

APA

Bolcaen, J., Nair, S., Driver, C. H. S., Boshomane, T. M. G., Ebenhan, T., & Vandevoorde, C. (2021). Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals (Basel, Switzerland), 14(7). https://doi.org/10.3390/ph14070626

Chicago

Bolcaen, Julie, Shankari Nair, Cathryn H S Driver, Tebatso M G Boshomane, Thomas Ebenhan, and Charlot Vandevoorde. 2021. “Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.” Pharmaceuticals (Basel, Switzerland) 14 (7). doi:10.3390/ph14070626.